In sporadic MTC, the presence of a somatic RET mutation, particularly M918T, has been found to correlate with more aggressive tumor features, a more advanced stage at diagnosis and a worse prognosis [22,23]. This evidence concerns the gene RET and medullary thyroid gland carcinoma.